This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Satake, M.
Right arrow Articles by Ito, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satake, M.
Right arrow Articles by Ito, Y.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Mar 1995, 1662-1670, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development

M Satake, S Nomura, Y Yamaguchi-Iwai, Y Takahama, Y Hashimoto, M Niki, Y Kitamura and Y Ito
Department of Viral Oncology, Kyoto University, Japan.

The PEBP2 alpha A and PEBP2 alpha B genes encode the DNA-binding subunit of a murine transcription factor, PEBP2, which is implicated as a T-cell-specific transcriptional regulator. These two related genes share the evolutionarily conserved region encoding the Runt domain. PEBP2 alpha B is the murine counterpart of human AML1, which is located at the breakpoints of the 8;21 and 3;21 chromosome translocations associated with acute myeloid leukemia. Northern (RNA) blots of various adult mouse tissues revealed that the levels of expression of both genes were most prominent in the thymus. Furthermore, transcripts of PEBP2 alpha A and mouse AML1/PEBP2 alpha B were detected in T lymphocytes in the thymuses from day 16 embryos and newborns, as well as 4-week-old adult mice, by in situ hybridization. The expression of the genes persisted in peripheral lymph nodes of adult mice. The transcripts were detected in all the CD4- CD8-, CD4+ CD8+, CD4+ CD8-, and CD4- CD8+ cell populations. The results indicated that both genes are expressed in T cells throughout their development, supporting the notion that PEBP2 is a T-cell-specific transcription factor. Transcripts of mouse AML1/PEBP2 alpha B were also detected in day 12 fetal hematopoietic liver and in the bone marrow cells of newborn mice. The implication of mouse AML1/PEBP2 alpha B expression in hematopoietic cells other than those of T-cell lineage is discussed in relation to myeloid leukemogenesis.


This article has been cited by other articles:

  • Endo, T., Ohta, K., Kobayashi, T. (2008). Expression and Function of Cbfa-1/Runx2 in Thyroid Papillary Carcinoma Cells. J. Clin. Endocrinol. Metab. 93: 2409-2412 [Abstract] [Full Text]  
  • Jo, M., Curry, T. E. Jr. (2006). Luteinizing Hormone-Induced RUNX1 Regulates the Expression of Genes in Granulosa Cells of Rat Periovulatory Follicles. Mol. Endocrinol. 20: 2156-2172 [Abstract] [Full Text]  
  • Kawagoe, H., Grosveld, G. C. (2005). MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice. Blood 106: 4278-4286 [Abstract] [Full Text]  
  • Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S., Lian, J. B. (2005). The Runx2 Osteogenic Transcription Factor Regulates Matrix Metalloproteinase 9 in Bone Metastatic Cancer Cells and Controls Cell Invasion. Mol. Cell. Biol. 25: 8581-8591 [Abstract] [Full Text]  
  • Kawazu, M., Asai, T., Ichikawa, M., Yamamoto, G., Saito, T., Goyama, S., Mitani, K., Miyazono, K., Chiba, S., Ogawa, S., Kurokawa, M., Hirai, H. (2005). Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCR{beta} Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development. J. Immunol. 174: 3526-3533 [Abstract] [Full Text]  
  • Qiao, M., Shapiro, P., Kumar, R., Passaniti, A. (2004). Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway. J. Biol. Chem. 279: 42709-42718 [Abstract] [Full Text]  
  • Xiao, Z.-S., Hjelmeland, A. B., Quarles, L. D. (2004). Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis. J. Biol. Chem. 279: 20307-20313 [Abstract] [Full Text]  
  • Castilla, L. H., Perrat, P., Martinez, N. J., Landrette, S. F., Keys, R., Oikemus, S., Flanegan, J., Heilman, S., Garrett, L., Dutra, A., Anderson, S., Pihan, G. A., Wolff, L., Liu, P. P. (2004). Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 101: 4924-4929 [Abstract] [Full Text]  
  • Telfer, J. C., Hedblom, E. E., Anderson, M. K., Laurent, M. N., Rothenberg, E. V. (2004). Localization of the Domains in Runx Transcription Factors Required for the Repression of CD4 in Thymocytes. J. Immunol. 172: 4359-4370 [Abstract] [Full Text]  
  • Lorsbach, R. B., Moore, J., Ang, S. O., Sun, W., Lenny, N., Downing, J. R. (2004). Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood 103: 2522-2529 [Abstract] [Full Text]  
  • Sowa, H., Kaji, H., Iu, M. F., Tsukamoto, T., Sugimoto, T., Chihara, K. (2003). Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts. J. Biol. Chem. 278: 52240-52252 [Abstract] [Full Text]  
  • Roper, R. J., McAllister, R. D., Biggins, J. E., Michael, S. D., Min, S. H., Tung, K. S. K., Call, S. B., Gao, J., Teuscher, C. (2003). Aod1 Controlling Day 3 Thymectomy-Induced Autoimmune Ovarian Dysgenesis in Mice Encompasses Two Linked Quantitative Trait Loci with Opposing Allelic Effects on Disease Susceptibility. J. Immunol. 170: 5886-5891 [Abstract] [Full Text]  
  • Wotton, S., Stewart, M., Blyth, K., Vaillant, F., Kilbey, A., Neil, J. C., Cameron, E. R. (2002). Proviral Insertion Indicates a Dominant Oncogenic Role for Runx1/AML-1 in T-Cell Lymphoma. Cancer Res. 62: 7181-7185 [Abstract] [Full Text]  
  • Kummalue, T., Lou, J., Friedman, A. D. (2002). Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Mol. Cell. Biol. 22: 8278-8291 [Abstract] [Full Text]  
  • Vaillant, F., Blyth, K., Andrew, L., Neil, J. C., Cameron, E. R. (2002). Enforced Expression of Runx2 Perturbs T Cell Development at a Stage Coincident with {beta}-Selection. J. Immunol. 169: 2866-2874 [Abstract] [Full Text]  
  • Stewart, M., MacKay, N., Cameron, E. R., Neil, J. C. (2002). The Common Retroviral Insertion Locus Dsi1 Maps 30 Kilobases Upstream of the P1 Promoter of the Murine Runx3/Cbfa3/Aml2 Gene. J. Virol. 76: 4364-4369 [Abstract] [Full Text]  
  • Hayashi, K., Abe, N., Watanabe, T., Obinata, M., Ito, M., Sato, T., Habu, S., Satake, M. (2001). Overexpression of AML1 Transcription Factor Drives Thymocytes into the CD8 Single-Positive Lineage. J. Immunol. 167: 4957-4965 [Abstract] [Full Text]  
  • Banerjee, C., Javed, A., Choi, J.-Y., Green, J., Rosen, V., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S. (2001). Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the Osteoblast Phenotype. Endocrinology 142: 4026-4039 [Abstract] [Full Text]  
  • Karsenty, G. (2001). Minireview: Transcriptional Control of Osteoblast Differentiation. Endocrinology 142: 2731-2733 [Abstract] [Full Text]  
  • Mertz, J. A., Mustafa, F., Meyers, S., Dudley, J. P. (2001). Type B Leukemogenic Virus Has a T-Cell-Specific Enhancer That Binds AML-1. J. Virol. 75: 2174-2184 [Abstract] [Full Text]  
  • Hayashi, K., Natsume, W., Watanabe, T., Abe, N., Iwai, N., Okada, H., Ito, Y., Asano, M., Iwakura, Y., Habu, S., Takahama, Y., Satake, M. (2000). Diminution of the AML1 Transcription Factor Function Causes Differential Effects on the Fates of CD4 and CD8 Single-Positive T Cells. J. Immunol. 165: 6816-6824 [Abstract] [Full Text]  
  • Pozner, A., Goldenberg, D., Negreanu, V., Le, S.-Y., Elroy-Stein, O., Levanon, D., Groner, Y. (2000). Transcription-Coupled Translation Control of AML1/RUNX1 Is Mediated by Cap- and Internal Ribosome Entry Site-Dependent Mechanisms. Mol. Cell. Biol. 20: 2297-2307 [Abstract] [Full Text]  
  • Goetz, T. L., Gu, T.-L., Speck, N. A., Graves, B. J. (2000). Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor alpha 2. Mol. Cell. Biol. 20: 81-90 [Abstract] [Full Text]  
  • Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J. R., Abe, T. (2000). Biological Characteristics of the Leukemia-Associated Transcriptional Factor AML1 Disclosed by Hematopoietic Rescue of AML1-Deficient Embryonic Stem Cells by Using a Knock-in Strategy. Mol. Cell. Biol. 20: 319-328 [Abstract] [Full Text]  
  • Le, X.-F., Groner, Y., Kornblau, S. M., Gu, Y., Hittelman, W. N., Levanon, D., Mehta, K., Arlinghaus, R. B., Chang, K.-S. (1999). Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor alpha -Dependent Signaling Pathway. J. Biol. Chem. 274: 21651-21658 [Abstract] [Full Text]  
  • Lewis, A. F., Stacy, T., Green, W. R., Taddesse-Heath, L., Hartley, J. W., Speck, N. A. (1999). Core-Binding Factor Influences the Disease Specificity of Moloney Murine Leukemia Virus. J. Virol. 73: 5535-5547 [Abstract] [Full Text]  
  • STEIN, G. S., VAN WIJNEN, A. J., STEIN, J. L., LIAN, J. B., POCKWINSE, S. H., MCNEIL, S. (1999). Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions. FASEB J. 13: 157-166 [Abstract] [Full Text]  
  • Harada, H., Tagashira, S., Fujiwara, M., Ogawa, S., Katsumata, T., Yamaguchi, A., Komori, T., Nakatsuka, M. (1999). Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation. J. Biol. Chem. 274: 6972-6978 [Abstract] [Full Text]  
  • Kawamoto, H., Ohmura, K., Fujimoto, S., Katsura, Y. (1999). Emergence of T Cell Progenitors Without B Cell or Myeloid Differentiation Potential at the Earliest Stage of Hematopoiesis in the Murine Fetal Liver. J. Immunol. 162: 2725-2731 [Abstract] [Full Text]  
  • North, T, Gu, T., Stacy, T, Wang, Q, Howard, L, Binder, M, Marin-Padilla, M, Speck, N. (1999). Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126: 2563-2575 [Abstract]  
  • Shi, M.-J., Stavnezer, J. (1998). CBF{alpha}3 (AML2) Is Induced by TGF-{beta}1 to Bind and Activate the Mouse Germline Ig {alpha} Promoter. J. Immunol. 161: 6751-6760 [Abstract] [Full Text]  
  • Stewart, M., Terry, A., Hu, M., O'Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., Neil, J. C. (1997). Proviral insertions induce the expression of bone-specific isoforms of PEBP2alpha A (CBFA1): Evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94: 8646-8651 [Abstract] [Full Text]  
  • Babichuk, C. K., Bleackley, R. C. (1997). Mutational Analysis of the Murine Granzyme B Gene Promoter in Primary T Cells and a T Cell Clone. J. Biol. Chem. 272: 18564-18571 [Abstract] [Full Text]  
  • Tenen, D. G., Hromas, R., Licht, J. D., Zhang, D.-E. (1997). Transcription Factors, Normal Myeloid Development, and Leukemia. Blood 90: 489-519 [Full Text]  
  • Zeng, C., van Wijnen, A. J., Stein, J. L., Meyers, S., Sun, W., Shopland, L., Lawrence, J. B., Penman, S., Lian, J. B., Stein, G. S., Hiebert, S. W. (1997). Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94: 6746-6751 [Abstract] [Full Text]  
  • Niki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M., Noda, T. (1997). Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA 94: 5697-5702 [Abstract] [Full Text]  
  • Lauzurica, P., Zhong, X.-P., Krangel, M. S., Roberts, J. L. (1997). Regulation of T Cell Receptor {delta} Gene Rearrangement by CBF/PEBP2. JEM 185: 1193-1202 [Abstract] [Full Text]  
  • Mayall, T P, Sheridan, P L, Montminy, M R, Jones, K A (1997). Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro.. Genes Dev. 11: 887-899 [Abstract]  
  • Corsetti, M. T., Calabi, F. (1997). Lineage- and Stage-Specific Expression of Runt Box Polypeptides in Primitive and Definitive Hematopoiesis. Blood 89: 2359-2368 [Abstract] [Full Text]  
  • Bruhn, L, Munnerlyn, A, Grosschedl, R (1997). ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.. Genes Dev. 11: 640-653 [Abstract]  
  • Babichuk, C. K., Duggan, B. L., Bleackley, R. C. (1996). In Vivo Regulation of Murine Granzyme B Gene Transcription in Activated Primary T Cells. J. Biol. Chem. 271: 16485-16493 [Abstract] [Full Text]  
  • Armesilla, A. L., Calvo, D., Vega, M. A. (1996). Structural and Functional Characterization of the Human CD36 Gene Promoter. J. Biol. Chem. 271: 7781-7787 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»